Wolfgang Galetzka, Germany

InGef - Institute for Applied Health Research Epidemiology

Poster Author Of 1 e-Poster

Online Abstracts Population Sciences - Epidemiology, Economics, and Mathematical Modelling D1 Epidemiology, Economics, and Mathematical Modelling

Author Of 1 Presentation

CLINICAL AND ECONOMIC BURDEN OF PNEUMOCOCCAL DISEASE AMONG INDIVIDUALS AGED 16 YEARS AND OLDER IN GERMANY (ID 748)

Abstract

Background

The study assessed the incidence rate of all-cause pneumonia (ACP) and invasive pneumococcal disease (IPD) and associated direct medical costs among individuals aged 16 years and older in Germany.

Methods

ACP and IPD were identified using ICD-10-GM codes in the InGef database from 2014 to 2017. Incidence rate was expressed as the number of episodes per 100,000 person-years. Direct medical costs were estimated as the total cost of all inpatient and outpatient visits, divided by the total number of episodes.

Results

The annual incidence of IPD per 100,000 person-years were as follows: 16 to 49 years: 7.2; 50 to 59 years: 29.4; 60 to 69 years: 69.1; and >=70 years: 207.1. The annual incidence of ACP per 100,000 person-years were as follows: 16 to 49 years: 438.8; 50 to 59 years: 809.6; 60 to 69 years: 1199.5; and >=70 years: 2770.9. The mean direct medical costs for IPD and ACP per episode were estimated to be €4551 and €993 respectively. The aggregate direct medical costs for IPD and ACP were estimated to be €28.5 million and €117.7 million respectively.

Conclusions

The clinical and economic burden of IPD and ACP among German adults is substantial regardless of age.

Hide